Evo312
Evo312 is a dose-dependent inhibitor of protein kinase CβI (PKCβI) (IC50 is 117.34 nM) . Evo312 induces PANC-GR (acquired gemcitabine-resistant PC cells) cell cycle arrest and apoptosis by inhibiting PKCβ1 protein expression. Evo312 has antiproliferative effects in pancreatic cancer cells PANC-1 and PANC-GR cells with IC50 of 0.08 μM and 0.07 μM, and in human normal pancreatic ductal epithelial cells HPDE6-c7 with IC50 of 2.95 μM. Evo312 exhibits antitumor activity in a PANC-GR cell transplantation mouse model[1].
Product Specifications
CAS Number
2820245-53-0
UNSPSC
12352005
Target
Apoptosis; PKC
Type
Reference compound
Related Pathways
Apoptosis; Epigenetics; TGF-beta/Smad
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/evo312.html
Smiles
O=C1C2=C(N(C3N1CCC4=C3NC5=CC=C(OC(C)=O)C=C45)C)C=CC=C2
Molecular Formula
C21H19N3O3
Molecular Weight
361.39
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PKCβ
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![(2S) -[3,4-Bis[[ (1,1-dimethylethyl) dimethylsilyl]oxy]phenyl]-1,2-propanediol](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
(2S) -[3,4-Bis[[ (1,1-dimethylethyl) dimethylsilyl]oxy]phenyl]-1,2-propanediol
